Daily dose of OND | Entire cohort (N = 51,342) | P | PSM cohort (10,724) | P | Circulatory system group in PSM cohort (n = 4599) | P |
---|---|---|---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
Nn-OND useors | Ref | Ref | Ref | |||
Low-dose OND users | 0.70 (0.60–0.83) | < 0.001 | 0.75 (0.62–0.90) | < 0.001 | 0.51 (0.36–0.73) | < 0.001 |
Moderate-dose OND users | 0.65 (0.45–0.94) | < 0.001 | 0.63 (0.43–0.91) | < 0.001 | 0.26 (0.11–0.65) | < 0.001 |
High-dose OND users | 1.58 (0.96–2.61) | 0.074 | 1.30 (0.78–2.16) | 0.311 | 1.51 (0.12–2.10) | 0.350 |